328 related articles for article (PubMed ID: 23762093)
1. Postmenopausal osteoporosis: the role of immune system cells.
Faienza MF; Ventura A; Marzano F; Cavallo L
Clin Dev Immunol; 2013; 2013():575936. PubMed ID: 23762093
[TBL] [Abstract][Full Text] [Related]
2. T-Cell Mediated Inflammation in Postmenopausal Osteoporosis.
Wu D; Cline-Smith A; Shashkova E; Perla A; Katyal A; Aurora R
Front Immunol; 2021; 12():687551. PubMed ID: 34276675
[TBL] [Abstract][Full Text] [Related]
3. A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab.
Tarantino U; Celi M; Feola M; Liuni FM; Resmini G; Iolascon G
Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S65-9. PubMed ID: 24046047
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal osteoporosis in rheumatoid arthritis: The estrogen deficiency-immune mechanisms link.
Sapir-Koren R; Livshits G
Bone; 2017 Oct; 103():102-115. PubMed ID: 28666971
[TBL] [Abstract][Full Text] [Related]
5. Bone anabolic versus bone anticatabolic treatment of postmenopausal osteoporosis.
Lyritis GP; Georgoulas T; Zafeiris CP
Ann N Y Acad Sci; 2010 Sep; 1205():277-83. PubMed ID: 20840284
[TBL] [Abstract][Full Text] [Related]
6. Interaction between bone and immune cells: Implications for postmenopausal osteoporosis.
Fischer V; Haffner-Luntzer M
Semin Cell Dev Biol; 2022 Mar; 123():14-21. PubMed ID: 34024716
[TBL] [Abstract][Full Text] [Related]
7. Experimental techniques for screening of antiosteoporotic activity in postmenopausal osteoporosis.
Satpathy S; Patra A; Ahirwar B
J Complement Integr Med; 2015 Dec; 12(4):251-66. PubMed ID: 26215536
[TBL] [Abstract][Full Text] [Related]
8. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data.
Dempster DW; Lambing CL; Kostenuik PJ; Grauer A
Clin Ther; 2012 Mar; 34(3):521-36. PubMed ID: 22440513
[TBL] [Abstract][Full Text] [Related]
9. Bone quality: what is it and how is it measured?
Compston J
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):579-85. PubMed ID: 17117283
[TBL] [Abstract][Full Text] [Related]
10. [Bone metabolism by sex hormones and gonadotropins].
Imai Y
Clin Calcium; 2014 Jun; 24(6):815-9. PubMed ID: 24870831
[TBL] [Abstract][Full Text] [Related]
11. Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss.
Stubelius A; Andersson A; Holmdahl R; Ohlsson C; Islander U; Carlsten H
BMC Musculoskelet Disord; 2016 Nov; 17(1):464. PubMed ID: 27829407
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy.
Mukherjee K; Chattopadhyay N
Biochem Pharmacol; 2016 Oct; 117():10-9. PubMed ID: 27106079
[TBL] [Abstract][Full Text] [Related]
13. Estrogens in rheumatoid arthritis; the immune system and bone.
Islander U; Jochems C; Lagerquist MK; Forsblad-d'Elia H; Carlsten H
Mol Cell Endocrinol; 2011 Mar; 335(1):14-29. PubMed ID: 20685609
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 27 (IL-27) Alleviates Bone Loss in Estrogen-deficient Conditions by Induction of Early Growth Response-2 Gene.
Shukla P; Mansoori MN; Kakaji M; Shukla M; Gupta SK; Singh D
J Biol Chem; 2017 Mar; 292(11):4686-4699. PubMed ID: 28130449
[TBL] [Abstract][Full Text] [Related]
15. Estrogen deficiency, T cells and bone loss.
Pacifici R
Cell Immunol; 2008; 252(1-2):68-80. PubMed ID: 17888417
[TBL] [Abstract][Full Text] [Related]
16. The treatment of osteoporosis. Antiresorptive therapy.
Miller PD
Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
[TBL] [Abstract][Full Text] [Related]
17. New therapeutical horizons in the management of postmenopausal osteoporosis.
Migliaccio S; Fornari R; Greco EA; Di Luigi L; Lenzi A
Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S117-9. PubMed ID: 24048905
[TBL] [Abstract][Full Text] [Related]
18. The immune system and postmenopausal osteoporosis.
D'Amelio P
Immunol Invest; 2013; 42(7):544-54. PubMed ID: 24004058
[TBL] [Abstract][Full Text] [Related]
19. RANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare disease.
Lo Iacono N; Pangrazio A; Abinun M; Bredius R; Zecca M; Blair HC; Vezzoni P; Villa A; Sobacchi C
Clin Dev Immunol; 2013; 2013():412768. PubMed ID: 23762088
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women.
Jordan N; Barry M; Murphy E
Clin Interv Aging; 2006; 1(4):377-87. PubMed ID: 18046915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
